Free Trial
NASDAQ:LFVN

Lifevantage (LFVN) Stock Price, News & Analysis

Lifevantage logo
$13.42 -0.16 (-1.21%)
As of 09:44 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Lifevantage Stock (NASDAQ:LFVN)

Key Stats

Today's Range
$13.80
$13.80
50-Day Range
$11.18
$13.59
52-Week Range
$5.22
$27.38
Volume
303 shs
Average Volume
154,786 shs
Market Capitalization
$169.03 million
P/E Ratio
19.58
Dividend Yield
1.34%
Price Target
$30.50
Consensus Rating
Buy

Company Overview

Lifevantage Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
86th Percentile Overall Score

LFVN MarketRank™: 

Lifevantage scored higher than 86% of companies evaluated by MarketBeat, and ranked 162nd out of 913 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Lifevantage has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Lifevantage has received no research coverage in the past 90 days.

  • Read more about Lifevantage's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Lifevantage is 19.70, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.86.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Lifevantage is 19.70, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.22.

  • Price to Book Value per Share Ratio

    Lifevantage has a P/B Ratio of 6.63. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Lifevantage's valuation and earnings.
  • Percentage of Shares Shorted

    20.38% of the float of Lifevantage has been sold short.
  • Short Interest Ratio / Days to Cover

    Lifevantage has a short interest ratio ("days to cover") of 12.6, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Lifevantage has recently increased by 3.52%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Lifevantage pays a meaningful dividend of 1.31%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Lifevantage has only been increasing its dividend for 3 years.

  • Dividend Coverage

    The dividend payout ratio of Lifevantage is 26.09%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Lifevantage's dividend.
  • Percentage of Shares Shorted

    20.38% of the float of Lifevantage has been sold short.
  • Short Interest Ratio / Days to Cover

    Lifevantage has a short interest ratio ("days to cover") of 12.6, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Lifevantage has recently increased by 3.52%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Lifevantage has a news sentiment score of 0.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Lifevantage this week, compared to 3 articles on an average week.
  • Search Interest

    3 people have searched for LFVN on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Lifevantage to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Lifevantage insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $36,769.00 in company stock.

  • Percentage Held by Insiders

    20.65% of the stock of Lifevantage is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 35.32% of the stock of Lifevantage is held by institutions.

  • Read more about Lifevantage's insider trading history.
Receive LFVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lifevantage and its competitors with MarketBeat's FREE daily newsletter.

LFVN Stock News Headlines

F1 Engineering Powers This Electric Marine Motor
The future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLaren Engineering, a NASDAQ-listed marine tech company unveiled a groundbreaking new electric powertrain set to transform the industry.
See More Headlines

LFVN Stock Analysis - Frequently Asked Questions

Lifevantage's stock was trading at $17.53 at the beginning of 2025. Since then, LFVN shares have decreased by 22.5% and is now trading at $13.59.

Lifevantage Corporation (NASDAQ:LFVN) issued its quarterly earnings data on Tuesday, May, 6th. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.16 by $0.10. The business earned $58.44 million during the quarter, compared to analyst estimates of $60.99 million. Lifevantage had a trailing twelve-month return on equity of 34.67% and a net margin of 4.12%.
Read the conference call transcript
.

Shares of LFVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lifevantage investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
5/06/2025
Record date for 6/13 Dividend
5/30/2025
Ex-Dividend for 6/13 Dividend
5/30/2025
Dividend Payable
6/13/2025
Today
7/07/2025
Next Earnings (Estimated)
8/27/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:LFVN
Employees
260
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$30.50
High Stock Price Target
$35.00
Low Stock Price Target
$26.00
Potential Upside/Downside
+124.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
19.70
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$2.94 million
Pretax Margin
5.65%

Debt

Sales & Book Value

Annual Sales
$200.16 million
Cash Flow
$0.87 per share
Price / Cash Flow
15.56
Book Value
$2.05 per share
Price / Book
6.63

Miscellaneous

Free Float
9,989,000
Market Cap
$171.10 million
Optionable
Optionable
Beta
0.43

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:LFVN) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners